REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 16th, 2006 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
This REGISTRATION RIGHTS AGREEMENT, dated as of October 17, 2005 (this “Agreement”), is made by and among Sonus Pharmaceuticals, Inc., a Delaware corporation, with headquarters located at 22026 20th Avenue S.E., Bothell, Washington 98021 (the “Company”), and Schering AG, a German corporation (“Schering AG”), and Schering Berlin Venture Corporation, a Delaware corporation (“SBVC”, and collectively with Schering AG, the “Investor”).
COLLABORATION AND LICENSE AGREEMENT between SONUS PHARMACEUTICALS, INC. and SCHERING AG Dated: October 17th 2005Collaboration and License Agreement • March 16th, 2006 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
This Collaboration and License Agreement (the “Agreement”) is made as of October 17, 2005 (the “Execution Date”) by and between Sonus Pharmaceuticals, Inc., a Delaware corporation (“Sonus”), and Schering AG, a German corporation (“Schering”). Sonus and Schering are sometimes referred to collectively herein as the “Parties” or singly as a “Party.”
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 16th, 2006 • Sonus Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of October 17, 2005 is made by and among Sonus Pharmaceuticals, Inc., a Delaware corporation, with headquarters located at 22026 20th Avenue S.E., Bothell, Washington 98021 (the “Company”), and Schering AG, a German corporation (“Schering AG”), and Schering Berlin Venture Corporation, a Delaware corporation (“SBVC”, and collectively with Schering AG, the “Investor”).
